Track topics on Twitter Track topics that are important to you
Phone: 44 (0) 1777 714 300
Fax: 44 (0) 1777 709 739
Robotics and automation will help improve the clunky and expensive clinical trial process, says Icon CEO â as the company continues to evaluate potential opportunities to improve efficiency.
(MedPage Today) -- Clinical benefit elusive long after polymer should have disappeared
Icon has launched an integrated technology platform for the design, simulation, and analysis of adaptive clinical trials.
(Cardiovascular Research Foundation) The first large, randomized trial comparing a novel polymer-free amphilimus-eluting stent to the latest-generation permanent polymer drug-eluting stent found that ...
ICON’s CEO Steve Cutler talks candidly about the impact of biotech funding, disruptive tech providers, and the constant pressure of...
Icon and Practice Fusion have teamed up to meet the expanding demand for real world evidence â and aim to transform the way research is conducted.
(University of Akron) Abraham Joy, a polymer science professor at The University of Akron, received a $200,000 prize from the state of Ohio's Third Frontier Commission to create a polymer-based fiber ...
Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment USP (Sterile)
Tropicamide Ophthalmic Solution USP (Sterile)
Quik Gel Advanced Hand Sanitizing Gel
Erythromycin Ophthalmic Ointment USP, 0.5% (Sterile)
The Gamma Knife Icon™ comes with an image guidance system for tracking patient motion and correcting for inter- and intrafractional shifts, mainly used with frameless thermoplastic immobilization. T...
This phase 1 study evaluated the safety and tolerability of single intravitreous injections (IVIs) of ICON-1 (Iconic Therapeutics, South San Francisco, CA) in patients with neovascular age-related mac...
Polyethylene furanoate polymer is intended to be used as a food contact material. A PEF polymer sample was investigated for its oligomer composition by solvent extraction and using HRLC-MS. The 20 oli...
The effect of particle size on the dissolution behavior of the particles of amorphous solid dispersions (ASDs) of griseofulvin (GF), with 0-50% Kollidon® VA 64 as a crystallization inhibitor is inves...
Current standard audible medical alarms are difficult to learn and distinguish from one another. Auditory icons represent a new type of alarm that has been shown to be easier to learn and identify in ...
The aim of this study is to determine the effect of ICON on White spot lesions compared to CPP-ACPF plus.
The purpose of this study is to evaluate the safety and effects of repeated intravitreal injections of ICON-1 0.6 mg administered as maintenance therapy or in combination with aflibercept ...
This is a randomized cross over trial to compare quality of life and product performance between Icon reusable underwear versus standard disposable pad in patients with mild to moderate ur...
We include the patients who need painless invasive endoscopic precedure, we collect the dempgraphic data and apply the non-invasive device ICON on patients during the who procedure.
The aim of the study is to investigate the use of a new FDA-approved non-invasive bio-impedance cardiac monitor, ICON, to detect hemodynamic effects during sedation in children undergoing ...
The Icon Polymer Group is a world class global provider of technically complex and innovative elastomer solutions across a broad spectrum of industries requiring a versatile, viable and market-centred...
ICON was founded in 1990 by a group of experienced professionals, who were dedicated to providing the pharmaceutical and biotechnology industries with exceptional clinical research and biometric servi...
ICON Eyecare is a leading surgical and medical eye care provider, based out of Denver, CO. Since 1999, ICON has been building a Center of Ophthalmology Excellence empowered by an ...
ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic devel...
ICON plc. is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic deve...
We have published hundreds of Icon Polymer Group Ltd news stories on BioPortfolio along with dozens of Icon Polymer Group Ltd Clinical Trials and PubMed Articles about Icon Polymer Group Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Icon Polymer Group Ltd Companies in our database. You can also find out about relevant Icon Polymer Group Ltd Drugs and Medications on this site too.